These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Primary gonadal failure in men selectively amplifies the mass of follicle stimulating hormone (FSH) secreted per burst and increases the disorderliness of FSH release patterns: reversibility with testosterone replacement. Veldhuis JD; Iranmanesh A; Urban RJ Int J Androl; 1997 Oct; 20(5):297-305. PubMed ID: 16130274 [TBL] [Abstract][Full Text] [Related]
27. Short-term fasting selectively suppresses leptin pulse mass and 24-hour rhythmic leptin release in healthy midluteal phase women without disturbing leptin pulse frequency or its entropy control (pattern orderliness). Bergendahl M; Iranmanesh A; Evans WS; Veldhuis JD J Clin Endocrinol Metab; 2000 Jan; 85(1):207-13. PubMed ID: 10634388 [TBL] [Abstract][Full Text] [Related]
28. Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome. García-Rudaz MC; Ropelato MG; Escobar ME; Veldhuis JD; Barontini M Eur J Endocrinol; 1998 Dec; 139(6):621-30. PubMed ID: 9916868 [TBL] [Abstract][Full Text] [Related]
29. Evidence for attenuation of hypothalamic gonadotropin-releasing hormone (GnRH) impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure. Veldhuis JD; Wilkowski MJ; Zwart AD; Urban RJ; Lizarralde G; Iranmanesh A; Bolton WK J Clin Endocrinol Metab; 1993 Mar; 76(3):648-54. PubMed ID: 8445020 [TBL] [Abstract][Full Text] [Related]
30. Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women. Hall JE; Lavoie HB; Marsh EE; Martin KA J Clin Endocrinol Metab; 2000 May; 85(5):1794-800. PubMed ID: 10843154 [TBL] [Abstract][Full Text] [Related]
31. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380 [TBL] [Abstract][Full Text] [Related]
32. Joint basal and pulsatile hypersecretory mechanisms drive the monotropic follicle-stimulating hormone (FSH) elevation in healthy older men: concurrent preservation of the orderliness of the FSH release process: a general clinical research center study. Veldhuis JD; Iranmanesh A; Demers LM; Mulligan T J Clin Endocrinol Metab; 1999 Oct; 84(10):3506-14. PubMed ID: 10522987 [TBL] [Abstract][Full Text] [Related]
33. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. Arroyo A; Laughlin GA; Morales AJ; Yen SS J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532 [TBL] [Abstract][Full Text] [Related]
34. Pulsatile luteinizing hormone patterns in long term oral contraceptive users. Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046 [TBL] [Abstract][Full Text] [Related]
35. Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men. Veldhuis JD; Lizarralde G; Iranmanesh A J Clin Endocrinol Metab; 1992 Jan; 74(1):96-102. PubMed ID: 1727834 [TBL] [Abstract][Full Text] [Related]
36. Disparate serum free testosterone concentrations and degrees of hypothalamo-pituitary-luteinizing hormone suppression are achieved by continuous versus pulsatile intravenous androgen replacement in men: a clinical experimental model of ketoconazole-induced reversible hypoandrogenemia with controlled testosterone add-back. Zwart AD; Iranmanesh A; Veldhuis JD J Clin Endocrinol Metab; 1997 Jul; 82(7):2062-9. PubMed ID: 9215273 [TBL] [Abstract][Full Text] [Related]
37. Evidence that androgen negative feedback regulates hypothalamic gonadotropin-releasing hormone impulse strength and the burst-like secretion of biologically active luteinizing hormone in men. Veldhuis JD; Urban RJ; Dufau ML J Clin Endocrinol Metab; 1992 Jun; 74(6):1227-35. PubMed ID: 1592863 [TBL] [Abstract][Full Text] [Related]
38. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion. Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179 [TBL] [Abstract][Full Text] [Related]
39. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men. Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115 [TBL] [Abstract][Full Text] [Related]
40. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. Friend K; Iranmanesh A; Login IS; Veldhuis JD Eur J Endocrinol; 1997 Oct; 137(4):377-86. PubMed ID: 9368506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]